Association of High-Level Mupirocin Resistance and Multidrug-Resistant Methicillin-Resistant Staphylococcus aureus at an Academic Center in the Midwestern United States
- 1 January 2011
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 49 (1), 95-100
- https://doi.org/10.1128/jcm.00759-10
Abstract
Mupirocin is a topical antimicrobial used to eradicate methicillin-resistant Staphylococcus aureus (MRSA) colonization, usually in the absence of susceptibility testing. We hypothesized that high-level (HL) mupirocin resistance was associated with multidrug resistance (MDR). To this end, unique patient isolates identified at our institution during 2008 were stratified into those resistant to ≥3 non-β-lactam antimicrobial classes (MDR) and non-MDR MRSA. HL mupirocin resistance was screened by mupA PCR on all MDR isolates ( n = 191) and a 20% random sample ( n = 130) of non-MDR isolates; E-testing confirmed HL resistance. We found that among MDR isolates, 13 (6.8%) carried mupA , whereas none of the non-MDR isolates did ( P = 0.001). Thus, although the overall prevalence of HL mupirocin resistance is low among MRSA isolates at our institution, an association exists between mupA carriage and MDR. Using genotyping and antimicrobial susceptibility profiling, we identified nine HL mupirocin-resistant clones. Whereas the majority of mupA -negative MDR isolates had a health care-associated MRSA (HA-MRSA) genotype (multilocus sequence type 5 [ST5] or SCC mec type II), the majority of mupA -positive MDR isolates had a community-associated MRSA (CA-MRSA) genotype (ST8 or SCC mec type IV). However, CA- and HA-MRSA genotypes were more evenly distributed among mupA -positive isolates compared to mupA -negative MDR isolates. Thus, in Chicago, mupA is circulating among both CA- and HA-MRSA backgrounds.Keywords
This publication has 32 references indexed in Scilit:
- Association of High-Level Mupirocin Resistance and Multidrug-Resistant Methicillin-Resistant Staphylococcus aureus at an Academic Center in the Midwestern United StatesJournal of Clinical Microbiology, 2011
- Emergence of Resistance among USA300 Methicillin-Resistant Staphylococcus aureus Isolates Causing Invasive Disease in the United StatesAntimicrobial Agents and Chemotherapy, 2010
- Mupirocin Resistance among Methicillin-ResistantStaphylococcus aureus-Colonized Patients at Admission to a Tertiary Care Medical CenterJournal of Clinical Microbiology, 2009
- Mupirocin resistance among staphylococci: trends in the southern region of IrelandJournal of Antimicrobial Chemotherapy, 2009
- Mupirocin-Resistant, Methicillin-Resistant Staphylococcus aureus Strains in Canadian HospitalsAntimicrobial Agents and Chemotherapy, 2007
- High Frequencies of Clindamycin and Tetracycline Resistance in Methicillin-Resistant Staphylococcus aureus Pulsed-Field Type USA300 Isolates Collected at a Boston Ambulatory Health CenterJournal of Clinical Microbiology, 2007
- Phenotypic and Genotypic Mupirocin Resistance among Staphylococci Causing Prosthetic Joint InfectionJournal of Clinical Microbiology, 2005
- Methicillin-ResistantStaphylococcus aureusDisease in Three CommunitiesNew England Journal of Medicine, 2005
- Staphylococcus aureusNasal Carriage in a Student Community Prevalence, Clonal Relationships, and Risk FactorsInfection Control & Hospital Epidemiology, 2004
- Mupirocin Resistance in Clinical Isolates ofStaphylococcus aureusInfection Control & Hospital Epidemiology, 2003